Related Experiment Video
Updated: Nov 16, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
New Developments in the Management of Cutaneous Squamous Cell Carcinoma
Thomas J Knackstedt1, Rebecca W Knackstedt1, Michelle Djohan1
1From the Department of Dermatology MetroHealth Hospital; School of Medicine, Case Western Reserve University; the Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation; and the College of Medicine and Life Sciences, University of Toledo.
Learning Objectives:
After studying this article, the participant should be able to: 1. List important prognostic features that affect cutaneous squamous cell carcinoma risk. 2. Summarize the changes to the AJCC Cancer Staging Manual, Eighth Edition, staging system for cutaneous squamous cell carcinoma. 3. Evaluate the draining nodal basin with appropriate imaging modalities. 4. Recommend adjuvant radiation therapy in the correct clinical setting for high-risk tumors. 5. Recognize the currently available treatments for advanced cutaneous squamous cell carcinoma.
Summary:
This continuing medical education article reviews the features, management, and prognosis of cutaneous squamous cell carcinoma with an emphasis on high-risk squamous cell carcinoma and data from the past 3 years. This review will discuss the primary tumor management, high-risk features of a squamous cell carcinoma, changes to the American Joint Committee on Cancer staging system, and the utility of sentinel lymph node biopsy, and critically review the evidence regarding adjuvant therapy.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy

